Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
Conditions
Interventions
Trofinetide
Placebo
Locations
21
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Translational Gemomics Research Institute (TGen)
Phoenix, Arizona, United States
University of California, San Diego
La Jolla, California, United States
UC Davis MIND Institute
Sacramento, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Children Medical Services
Tampa, Florida, United States
Start Date
November 6, 2019
Primary Completion Date
October 28, 2021
Completion Date
October 28, 2021
Last Updated
April 8, 2024
NCT06139172
NCT06338267
NCT05740761
NCT06856759
NCT06705816
NCT04463316
Lead Sponsor
ACADIA Pharmaceuticals Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions